Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc. (KPTI)

Market is closed
Latest 13D & 13G Filings
Company Symbol Filed By Filing Date Filing
Karyopharm Therapeutics Inc.
KPTI
 Integrated Core Strategies (US) LLC 2026-04-13
13G Filing
Karyopharm Therapeutics Inc.
KPTI
RA Capital Management
 2026-04-02
13G Filing
Karyopharm Therapeutics Inc.
KPTI
Commodore Capital
 2026-04-02
13G Filing
Karyopharm Therapeutics Inc.
KPTI
 T. Rowe Price Investment Management, Inc. 2026-02-17
13G Filing
Karyopharm Therapeutics Inc.
KPTI
 Adage Capital Management, L.P. 2026-02-12
13G Filing
Insider Monkey Quarterly Strategy
+498.7% Insider Monkey Quarterly Strategy
+195% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
400%
200%
0%

Returns since its inception in May 2014 (through February 18th, 2026)

Subscribe Now

30 day money back guarantee. Cancel anytime.